Trial intelligence / Profile preview

RBC Transfusion Types in Septic Patients' Microcirculation

NCT01584999Phase 4Completed

Sponsor
Università Politecnica delle Marche
Start
Feb 2011
Primary completion
Feb 2012
Modality
Recombinant Proteins and Enzymes, Cell Therapies
Countries
1
01

Overview

Phase 4, randomised, open-label trial of red blood cells in sepsis (3 arms), sponsored by Università Politecnica delle Marche. Primary endpoint: Microcirculatory Flow Index at 1 hour. Started Feb 2011; status: completed.

02

Drugs

red blood cells
03

Conditions

sepsis

Beyond the preview

Go deeper on NCT01584999.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01584999.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call